Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. - Wikidata - awgldk - TriplyDB

Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics.

Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics.

http://www.wikidata.org/entity/Q33766404

about

The macrophages in rheumatic diseases Ectopic Lymphoid Structures: Powerhouse of Autoimmunity Biomarkers to guide clinical therapeutics in rheumatology?Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study Ectopic lymphoid neogenesis in rheumatic autoimmune diseases.Influence of anti-TNF immunogenicity on safety in rheumatic disease: a narrative review.Can Synovial Pathobiology Integrate with Current Clinical and Imaging Prediction Models to Achieve Personalized Health Care in Rheumatoid Arthritis?In search of magic bullets: the golden age of immunotherapeutics.Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasome The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis.Is there a role of synovial biopsy in drug development?Higher expression of TNFα-induced genes in the synovium of patients with early rheumatoid arthritis correlates with disease activity, and predicts absence of response to first line therapy.Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study Integration of known DNA, RNA and protein biomarkers provides prediction of anti-TNF response in rheumatoid arthritis: results from the COMBINE study.MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis.Lipid and Metabolic Changes in Rheumatoid Arthritis.Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways.Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases.Cytokines in rheumatoid arthritis - shaping the immunological landscape.Biomarkers in the clinical development of asthma therapies.Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.Selected cytokine pathways in rheumatoid arthritis.Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis.The burgeoning field of innate immune-mediated disease and autoinflammation.Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics.Arthroscopic guided synovial biopsy in rheumatology: current perspectives.Synovial cellular and molecular markers in rheumatoid arthritis.Cellular and molecular perspectives in rheumatoid arthritis.Confirmation of an IRAK3 polymorphism as a genetic marker predicting response to anti-TNF treatment in rheumatoid arthritis.Synovial tissue research: a state-of-the-art review.Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF+ T Lymphocytes.Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?Synovial fibroblasts in 2017.Moving towards personalized medicine in rheumatoid arthritis.Synovial tissue macrophages: friend or foe?Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis.IL-27 - a double agent in the IL-6 family.Targeted antibody therapy and relevant novel biomarkers for precision medicine for rheumatoid arthritis.Association of tumor necrosis factor-α (G-308A) genetic variant with matrix metalloproteinase-9 activity and joint destruction in early rheumatoid arthritis.

P2860

Q26765275-3468CE74-9A16-4ABC-851D-7C77B86A843E Q28071579-0706159D-D913-4746-8542-BE339EF70003 Q28080053-1A79D730-0F0A-4892-BA0C-02A57BEAF59A Q28084913-10A238E5-2BC1-4BED-82CF-CF30416A3F09 Q28551216-E3DF1AF2-8DD2-4336-80C7-94BF3C78BA83 Q30235935-2A1FE327-AF93-49D1-84A0-C2C01001C7B4 Q30240229-D48D98D8-6360-447F-ABCC-F626AA27B723 Q33627758-62EB50CF-AFA4-4C6C-B3ED-C83595BEBC57 Q34356481-B3C2E943-3D8C-4BF3-A960-AD5E8BCB2E2B Q35694891-D3700709-5378-46C3-AC8D-FAB1B5B7279E Q35764862-C1A1EF1A-3419-418B-919F-BD1E054CA7C4 Q35994130-2941E6DB-E5E9-496B-8693-B6C395197D8D Q36480968-B0AD988C-48A1-4647-9B84-726E6EB80598 Q36825365-256A497F-C664-4452-9B23-D5EADFE5C8EF Q37256337-E0B48B3F-E637-4252-B12E-1518E96A5DCA Q37315021-C62CBD37-5E10-454C-96CC-CE909E47EF09 Q38554197-6185072B-B130-43CD-B16C-5E0A67602992 Q38597826-0C0171B3-276A-4B7A-B0FE-6FDD0FEA8B4F Q38635412-BF6C99A7-3506-4C52-9310-ABF9EBAE6314 Q38666239-7B22C831-0A4F-4FDB-9B08-DC1130CF6248 Q38695917-11D1104F-EC08-43FD-83F0-6CF187DEC922 Q38728689-EE26BA6B-5B5C-4993-9859-E299274FBF15 Q38755912-A5A9BAD8-BC61-4AAD-9C60-0167F74486BC Q38828876-98B1606F-CC0B-4B76-B7C5-E53803333304 Q38967233-DAF1D130-7572-4B6F-8909-3B7C66E39E12 Q38988559-E9D232AA-FDC7-4A79-B6EE-D2B7753278C7 Q39042968-E6A853E7-8486-4EE1-A899-D0C4C35C736C Q39301702-49F32477-BFEC-4D17-A327-E100A3B677B1 Q39308974-907EA1BF-9809-4F87-98C4-9717041F18BF Q39326581-D1431BC8-405B-4FF3-930B-BE5C5DBE21AA Q39431367-7BE2A140-4BFE-4AD2-9754-46948F5CBACC Q42113714-DE730E62-792D-4967-80E2-54E118A994FD Q42633541-10281A33-6EC0-4278-BB85-627FDFD43D1C Q42650240-F07B77CA-B982-42EA-B8C2-88409D40F630 Q42699496-A75BE44C-3B3A-4625-B5B5-8EF55FB9F2EF Q47212014-86F88E6D-6F38-4479-8AB5-54D22ADBC72B Q48148502-38D26321-9BE2-430F-B701-638C44F5D0D8 Q50045633-C6D375D8-3852-484C-8F84-58CA7FDB08E8 Q50082712-B5051D6B-B1EF-411B-81B1-E288753DFDBC Q51343419-3C2A4999-6AAE-4C00-9ED7-35F6716B1193

P2860

Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics.

http://www.wikidata.org/entity/Q33766404

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Synovial phenotypes in rheumat ...... onse to biologic therapeutics.

@ast

Synovial phenotypes in rheumat ...... onse to biologic therapeutics.

@en

type

label

Synovial phenotypes in rheumat ...... onse to biologic therapeutics.

@ast

Synovial phenotypes in rheumat ...... onse to biologic therapeutics.

@en

prefLabel

Synovial phenotypes in rheumat ...... onse to biologic therapeutics.

@ast

Synovial phenotypes in rheumat ...... onse to biologic therapeutics.

@en

P1433

Q33766404-76D02B59-02A3-4DD4-A484-1621EF1BC230

P1476

Q33766404-5723DE0C-4374-4AFB-BA69-A84C1D242B19

P2093

Q33766404-09B471EF-358A-42AA-8C72-AA8247DEAB43

Q33766404-1787F64A-A4E3-4E98-920A-9DEAFA603CC5

Q33766404-29480AB3-FD67-47B9-A508-9A78E1E5B57F

Q33766404-4886888B-0813-438C-99EA-EED5B7A27A43

Q33766404-5ABE9B9F-18EB-4214-862E-EC0DB9210228

Q33766404-786E994F-4A06-442D-81C9-17E6FB979A4A

Q33766404-7AF7CAB6-C2F4-4841-B810-93D1CF0FF593

Q33766404-84FF00ED-27F9-441A-80E6-A4FFDD19D6F6

Q33766404-86DD3F0D-A1E4-4840-B058-A45EA9990F51

Q33766404-A98B2474-9584-4A9E-B62B-0C2CA2442795

P2860

Q33766404-0E03679B-CA84-4C6D-AAAB-1ED940745733

Q33766404-113563F1-FA4F-4166-99FA-7F78391BCBA2

Q33766404-1AB00194-DC21-4D80-9C35-08D48862E64C

Q33766404-1CB5A223-40A2-49D8-B7A6-A799F666720D

Q33766404-2BB7F658-7208-45E9-A72D-7E507312C275

Q33766404-2F71D222-C13E-4408-A403-61146FB98687

Q33766404-4FFBA70A-8BC9-43CF-8108-33723D61DAD9

Q33766404-534C895F-2AD2-4ABF-BADC-D271D4ACFEAC

Q33766404-54037A85-3EE0-4892-A5FF-B04686E79DCC

Q33766404-5436744E-6C13-4A0D-A6F7-5D74301A2ECE

P2888

Q33766404-D1A1CC07-7771-4D28-AD1D-A0F33918600E

P304

Q33766404-01DC6E17-664C-456F-B4BC-5DA677E849D2

P31

Q33766404-D6D35674-84A3-47E1-A213-D12E870EAC2D

P356

Q33766404-A7B98463-6D31-4773-9D4D-6535A28B12C0

P433

Q33766404-A2BB7359-2229-4565-B33C-BB438DC573ED

P478

Q33766404-E4C3003B-CD64-49C1-BDC0-9D94C65B71B0

P50

Q33766404-22074CC2-F77A-4E62-BA47-AC122CB8336E

Q33766404-2B0DF87C-8F8C-490F-93FD-B49B8BF6DC75

Q33766404-2FF605F4-2DC5-4F8F-8098-F56ACA332D83

P577

Q33766404-CED7A248-1D92-4739-9ACC-3437759AC741

P5875

Q33766404-E0B95E56-0D18-42AA-9C35-762899335172

P6179

Q33766404-2F9A593C-6B3F-489A-925B-FDDD897DB5DC

P698

Q33766404-9A1115A7-DC66-4E71-BA52-0050A4BF3EDE

P932

Q33766404-8E771421-0434-4853-BD5D-43DCC0BDBB46

P356

P1433

Arthritis Research and Therapy

P1476

Synovial phenotypes in rheumat ...... ponse to biologic therapeutics

@en

P2093

A Francesca Setiadi

http://www.w3.org/2001/XMLSchema#string

An Song

http://www.w3.org/2001/XMLSchema#string

Arthur Kavanaugh

http://www.w3.org/2001/XMLSchema#string

Cem Gabay

http://www.w3.org/2001/XMLSchema#string

Cécile T J Holweg

http://www.w3.org/2001/XMLSchema#string

David A Fox

http://www.w3.org/2001/XMLSchema#string

David Musselman

http://www.w3.org/2001/XMLSchema#string

Flavius Martin

http://www.w3.org/2001/XMLSchema#string

Glynn Dennis

http://www.w3.org/2001/XMLSchema#string

Houston Gilbert

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

NCBI GEO: archive for functional genomics data sets--10 years on

DAVID: Database for Annotation, Visualization, and Integrated Discovery

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

TNF-R1 signaling: a beautiful pathway

More powerful procedures for multiple significance testing

P2888

P304

R90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR4555

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Jason A. Hackney

Sarah K Kummerfeld

P577

2014-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264552007

http://www.w3.org/2001/XMLSchema#string

P6179

1009304916

http://www.w3.org/2001/XMLSchema#string

P698

25167216

http://www.w3.org/2001/XMLSchema#string

P932

4060385

http://www.w3.org/2001/XMLSchema#string